New Zealand markets closed

bioAffinity Technologies, Inc. (BIAFW)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.5300+0.0300 (+6.00%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-8,366
-7,937
-8,154
-6,326
-7,269
Depreciation & amortisation
377.545
249.592
10.182
4.817
22.242
Stock-based compensation
874.922
748.823
248.592
43.012
275.732
Change in working capital
258.829
900.79
114.203
632.821
482.62
Inventory
1.848
-12.944
-5.54
0
-
Accounts payable
-36.792
-14.501
114.635
39.02
87.969
Other working capital
-6,887
-6,061
-4,291
-2,049
-2,211
Other non-cash items
-
-
3,923
-244.354
4,281
Net cash provided by operating activities
-6,855
-6,038
-4,071
-2,049
-2,208
Cash flows from investing activities
Investments in property, plant and equipment
-31.975
-22.902
-219.987
-
-2.888
Acquisitions, net
-
-2,186
0
-
-
Net cash used for investing activities
-2,218
-2,209
-219.987
0
-2.888
Cash flows from financing activities
Debt repayment
-350.333
-344.984
-694.983
0
-
Common stock issued
2,005
0
6,027
0
-
Other financing activities
-
-
-55.836
-180.75
-
Net cash used provided by (used for) financing activities
1,757
-344.984
14,344
3,327
1,715
Net change in cash
-7,316
-8,592
10,053
1,278
-495.375
Cash at beginning of period
9,769
11,414
1,361
83.108
578.483
Cash at end of period
2,453
2,822
11,414
1,361
83.108
Free cash flow
Operating cash flow
-6,855
-6,038
-4,071
-2,049
-2,208
Capital expenditure
-31.975
-22.902
-219.987
-
-2.888
Free cash flow
-6,887
-6,061
-4,291
-2,049
-2,211